Workflow
嘉应制药(002198) - 2023 Q1 - 季度财报
002198JYPC(002198)2023-04-28 16:00

Financial Performance - The company's revenue for Q1 2023 was CNY 128,497,088.51, representing a 6.56% increase compared to CNY 120,586,266.19 in the same period last year[5] - Net profit attributable to shareholders increased by 380.58% to CNY 12,185,969.05 from CNY 2,535,662.28 year-on-year[5] - The net profit after deducting non-recurring gains and losses was CNY 11,019,022.44, up 310.95% from CNY 2,681,378.06 in the previous year[5] - Basic and diluted earnings per share rose to CNY 0.0240, a 380.00% increase from CNY 0.0050 in the same quarter last year[5] - Total operating revenue for Q1 2023 was CNY 128,497,088.51, an increase of 6.9% compared to CNY 120,586,266.19 in Q1 2022[16] - Operating profit for Q1 2023 reached CNY 13,120,025.47, significantly up from CNY 3,888,881.56 in the same period last year, marking an increase of 237.5%[18] - Net profit attributable to the parent company was CNY 12,185,969.05, compared to CNY 2,535,662.28 in Q1 2022, representing a growth of 380.5%[19] - Basic and diluted earnings per share for Q1 2023 were both CNY 0.0240, up from CNY 0.0050 in Q1 2022[19] Assets and Liabilities - Total assets decreased by 1.83% to CNY 831,190,971.73 from CNY 846,650,977.26 at the end of the previous year[5] - The company's total assets as of March 31, 2023, amount to CNY 831,190,971.73, down from CNY 846,650,977.26 at the beginning of the year[14] - The total current assets decreased to CNY 548,050,880.96 from CNY 557,432,509.74[13] - The total non-current assets decreased to CNY 283,140,090.77 from CNY 289,218,467.52[14] - The total current liabilities decreased to CNY 55,332,590.34 from CNY 82,947,126.75[14] - The total non-current liabilities remained relatively stable at CNY 35,254,397.84 compared to CNY 35,285,836.01 at the beginning of the year[14] - Total liabilities decreased to CNY 90,586,988.18 from CNY 118,232,962.76 year-over-year[18] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 956,929.25, a decline of 187.25% compared to a net inflow of CNY 1,096,710.93 in the previous year[5] - Cash flow from operating activities showed a net outflow of CNY -956,929.25, a decrease from a net inflow of CNY 1,096,710.93 in the previous year[19] - The net cash flow from investment activities was -937,382.74 CNY, indicating a decrease compared to the previous quarter[20] - The total cash outflow from investment activities amounted to 51,324,780.00 CNY, with 50,000,000.00 CNY related to other investment activities[20] - The net cash flow from financing activities was -10,361,477.89 CNY, primarily due to debt repayment and dividend distributions[20] - The company reported a net decrease in cash and cash equivalents of 1,894,311.99 CNY for the quarter[20] - Cash and cash equivalents at the end of the reporting period are CNY 181,963,721.91, slightly down from CNY 183,858,033.90[13] Other Income and Expenses - The company received government subsidies amounting to CNY 1,378,263.01, contributing to a significant increase in other income by 8185.69%[8] - Other income increased to CNY 1,386,076.13 from CNY 16,728.56 in the previous year, indicating a significant rise in additional revenue sources[16] - The company reported a decrease in total operating costs to CNY 115,949,772.87 from CNY 116,699,221.13 in the previous year[16] - Research and development expenses were CNY 1,657,099.81, slightly down from CNY 1,737,267.90 in Q1 2022[16] Shareholder Information - The total number of common shareholders at the end of the reporting period is 26,688[10] - The top 10 shareholders hold a total of 11.27% (57,200,000 shares) by Dongfang Securities Co., Ltd.[10] Market Strategy - The company plans to continue expanding its market presence and investing in new product development to drive future growth[5] Audit Status - The first quarter report was not audited, which may affect the reliability of the financial data presented[20]